G. S. Crowther

Johns Hopkins University — United States

Medicine · Health Sciences

17h-index807citations30works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Clostridium difficile and Clostridium perfringens research(24), Microscopic Colitis(16), Helicobacter pylori-related gastroenterology studies(7), Gut microbiota and health(6), Gastrointestinal motility and disorders(6)

Publications30 total

Triple threat: Three typing assays resulted three different HLA-DPB1 typings
Human Immunology·2024
Efficacy of Topical Vancomycin- and Gentamicin-Loaded Calcium Sulfate Beads or Systemic Antibiotics in Eradicating Polymicrobial Biofilms Isolated from Diabetic Foot Infections within an <i>In Vitro</i> Wound Model
Antimicrobial Agents and Chemotherapy·2021· 11 citedOpen Access
Graphene Matrices as Carriers for Metal Ions against Antibiotic Susceptible and Resistant Bacterial Pathogens
Coatings·2021· 9 citedOpen Access
Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis
Cells·2020· 65 citedOpen Access
Investigation of the effect of the adsorbent DAV131A on the propensity of moxifloxacin to induce simulated Clostridioides (Clostridium) difficile infection (CDI) in an in vitro human gut model
Journal of Antimicrobial Chemotherapy·2020· 3 citedOpen Access
Effectiveness of titanium nitride silver coatings against Staphylococcus spp. in the presence of BSA and whole blood conditioning agents
International Biodeterioration & Biodegradation·2018· 10 citedOpen Access
71DEMENTIA INPATIENT STUDY ON THE RECOGNITION AND EVALUATION OF SIGNS SIGNALLING EMOTIONAL DISTRESS - THE DISTRESSED STUDY
Age and Ageing·2018Open Access
Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production
PLoS ONE·2016· 32 citedOpen Access
Potential of lactoferrin to prevent antibiotic-induced<i>Clostridium difficile</i>infection
Journal of Antimicrobial Chemotherapy·2016· 25 citedOpen Access
Efficacy of vancomycin extended-dosing regimens for treatment of simulated<i>Clostridium difficile</i>infection within an<i>in vitro</i>human gut model
Journal of Antimicrobial Chemotherapy·2016· 17 citedOpen Access
An In Vitro Model of the Human Colon: Studies of Intestinal Biofilms and Clostridium difficile Infection
Methods in molecular biology·2016· 15 cited
Antibiotic therapy and Clostridium difficile infection &amp;ndash; primum non nocere &amp;ndash; first do no harm
Infection and Drug Resistance·2015· 28 citedOpen Access
Efficacy of alternative fidaxomicin dosing regimens for treatment of simulated<i>Clostridium difficile</i>infection in an<i>in vitro</i>human gut model
Journal of Antimicrobial Chemotherapy·2015· 27 citedOpen Access
PTU-262 Effects of bovine lactoferrin in an<i>in vitro</i>human gut model of c. difficile infection
Gut·2015
Recurrence of dual-strain<i>Clostridium difficile</i>infection in an<i>in vitro</i>human gut model
Journal of Antimicrobial Chemotherapy·2015· 7 citedOpen Access
<i>In vitro</i> susceptibility of <i>Clostridium difficile</i> to SMT19969 and comparators, as well as the killing kinetics and post-antibiotic effects of SMT19969 and comparators against <i>C. difficile</i>
Journal of Antimicrobial Chemotherapy·2015· 40 citedOpen Access
SMT19969 as a treatment for Clostridium difficile infection: an assessment of antimicrobial activity using conventional susceptibility testing and an in vitro gut model
Journal of Antimicrobial Chemotherapy·2014· 42 citedOpen Access
Efficacy of surotomycin in an in vitro gut model of Clostridium difficile infection
Journal of Antimicrobial Chemotherapy·2014· 27 citedOpen Access
Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model
Journal of Antimicrobial Chemotherapy·2014· 46 citedOpen Access
Development and Validation of a Chemostat Gut Model To Study Both Planktonic and Biofilm Modes of Growth of Clostridium difficile and Human Microbiota
PLoS ONE·2014· 47 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

C. H. Chilton(21), Mark H. Wilcox(18), S. L. Todhunter(15), Jane Freeman(15), Simon D. Baines(9), Scott Nicholson(7), M. H. Wilcox(4), Christopher Longshaw(4), Richard Vickers(2), Jon J. Vernon(2), Helen Ashwin(2), Klaudyna Śpiewak(2), Małgorzata Brindell(2), Warren N. Fawley(2), Craig E. Banks(2), Kathryn A. Whitehead(2), Lucy Urwin(1), Katarzyna Okurowska(1), Sanhita Roy(1), Prashant Garg(1)